Strikingly, cells expressing PAI1 protein are more sensitive to PIM inhibitor AZD1208 (Figure 5), suggesting that PAI1 could be used to predict increased efficacy of this PIM inhibitor and may complement radiotherapy in rectal tumors. Here, SERPINE1 is linked to rectal neoplasm.